SEC Form 4 · accession 0001209191-19-000918
TANDEM DIABETES CARE INC · TNDM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John F Sheridan
Officer — EVP, CHIEF OPERATING OFFICER
Period of report
Dec 31, 2018
Accepted (ET)
Jan 3, 2019 · 4:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001438133
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 31, 2018 | S | 788 | $37.8135 | D | 666 | D | |
| Common StockF2 | Jan 2, 2019 | M | 20,000 | $2.59 | A | 20,666 | D | |
| Common StockF3 | Jan 2, 2019 | S | 4,599 | $36.23 | D | 16,067 | D | |
| Common StockF4 | Jan 2, 2019 | S | 15,401 | $35.51 | D | 666 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF5 | $2.59 | Jan 2, 2019 | M | 20,000 | D | — | Dec 1, 2027 | Common Stock | 20,000 | 80,000 | D |
Explanation of responses
- F1The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $37.75 and $37.85.
- F2Represents shares of common stock received upon exercise of a stock option award.
- F3The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $36.04 and $36.55.
- F4The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $35.02 and $35.87.
- F5Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter